Genovate Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Genovate Biotechnology has a total shareholder equity of NT$1.5B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.6B and NT$145.5M respectively. Genovate Biotechnology's EBIT is NT$27.0M making its interest coverage ratio -4.8. It has cash and short-term investments of NT$538.6M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -4.8x |
| Cash | NT$538.60m |
| Equity | NT$1.50b |
| Total liabilities | NT$145.53m |
| Total assets | NT$1.65b |
Recent financial health updates
No updates
Recent updates
Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years
Mar 09
Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?
Feb 10Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals
Jan 04
How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 08Financial Position Analysis
Short Term Liabilities: 4130's short term assets (NT$777.1M) exceed its short term liabilities (NT$137.1M).
Long Term Liabilities: 4130's short term assets (NT$777.1M) exceed its long term liabilities (NT$8.4M).
Debt to Equity History and Analysis
Debt Level: 4130 is debt free.
Reducing Debt: 4130 had no debt 5 years ago.
Debt Coverage: 4130 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4130 has no debt, therefore coverage of interest payments is not a concern.